glutathione palpitations Participation in the Prevention of Cardiovascular Diseases Biomedical Reports

The Bioavailability Barrier: Why Format Matters The most significant challenge with any glutathione supplement is its low oral bioavailability

Clinical studies reported that the pharmacotherapeutic agents utilized for the treatment of these two distinct conditions appear to exert ameliorative effects on the other condition as well

1 Introduction Brain is a major body organ that integrate several neurodegenerative diseases including Alzheimer disease (AD), Parkinson disease (PD), primary tauopathies, frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), synucleinopathies (such as Lewy body dementia [LBD] and multisystem atrophy [MSA]), polyglutamine-related diseases (Huntington disease (HD) and spinocerebellar ataxias [SCA]), prion disease (PrD), traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE), spinal cord injury (SCI), and multiple sclerosis (MS) (Wilson et al., 2023)

In addition to these scientific and technical hurdles, important ethical considerations must be taken into account